podophyllotoxin has been researched along with Granulocytic Leukemia in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (53.13) | 18.7374 |
| 1990's | 13 (40.63) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aparicio Urtasun, J; Díaz Beveridge, R | 1 |
| Hanada, S; Otsuka, M; Owatari, S; Takeshita, T; Uozumi, K | 1 |
| Fleischer, J; Franke, WG | 1 |
| Glode, LM; Mughal, TI; Robinson, WA; Thomas, MR | 1 |
| Crist, WM; Pui, CH; Rivera, GK | 1 |
| Behm, FG; Bowman, LC; Head, DR; Heaton, D; Hurwitz, CA; Pui, CH; Raimondi, SC; Sandoval, C | 1 |
| Murphy, SB | 1 |
| Cazenave, L; Gehan, E; Heyn, R; Khan, FM; Maurer, HM; Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Hancock, ML; Heslop, HE; Mahmoud, HH; Pui, CH; Raimondi, SC; Relling, MV; Ribeiro, RC; Rivera, GK; Sandlund, JT; Santana, VM | 1 |
| Bowman, WP; Buchanan, GR; Friedman, DJ; Mustafa, MM; Sandler, ES; Winick, NJ | 1 |
| Karp, JE; Smith, MA | 1 |
| Geisler, C; Myhre, J; Pedersen, M; Pedersen-Bjergaard, J | 1 |
| Felix, CA | 1 |
| Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D | 1 |
| Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB | 1 |
| Gétaz, EP; Staples, WG | 1 |
| Arnold, AM | 1 |
| Bernasconi, C; Lazzarino, M; Morra, E | 1 |
| Clink, HM; Gerken, ME; McElwain, TJ; Smith, IE | 1 |
| Batz, K; Brunner, KW; Cavalli, F; Ryssel, HJ; Sonntag, RW | 1 |
| Donaldson, MH; Rosenstock, JG | 1 |
| Ratain, MJ; Rowley, JD | 1 |
| Behm, FG; Evans, WE; Hancock, ML; Head, DR; Mahmoud, MH; Pui, CH; Raimondi, SC; Ribeiro, RC; Rivera, GK; Sandlund, JT | 1 |
| Pui, CH | 1 |
| Culbert, SJ; Frankel, LS; Shimizu, H | 1 |
| Blume, KG; Feinstein, DI; Forman, SJ; O'Donnell, MR | 1 |
| Gross, M; Ross, WE; Yalowich, JC; Zucali, JR | 1 |
| Burchenal, JH; Carter, SK | 1 |
| Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R | 1 |
| Bross, T; Bross, W; Olejak, B | 2 |
| Ishii, Y; Kihara, A; Noguchi, H; Noto, J; Ohara, H | 1 |
7 review(s) available for podophyllotoxin and Granulocytic Leukemia
| Article | Year |
|---|---|
[Therapy-related acute leukaemia and myelodysplastic syndrome].
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Neoplasms; Neoplasms, Second Primary; Palliative Care; Podophyllotoxin; Prognosis | 2003 |
The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention.
Topics: Acute Disease; Antineoplastic Agents, Alkylating; DNA Damage; DNA Repair; Humans; Leukemia, Myeloid; Molecular Epidemiology; Neoplasms, Second Primary; Podophyllotoxin | 1997 |
Secondary leukemias induced by topoisomerase-targeted drugs.
Topics: Antineoplastic Agents, Alkylating; Chromosome Breakage; DNA Damage; DNA-Binding Proteins; Genes, Neoplasm; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Podophyllotoxin; Proto-Oncogenes; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic | 1998 |
Podophyllotoxin derivative VP 16-213.
Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma | 1979 |
[Acute monocytic and myelomonocytic leukemias. Incidence and treatment with an epipodophyllotoxin derivative (VP 16.213)].
Topics: Adult; Age Factors; Drug Evaluation; Female; Humans; Italy; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin | 1975 |
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.
Topics: Acute Disease; Antineoplastic Agents; DNA Damage; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Topoisomerase II Inhibitors | 1992 |
New cancer chemotherapeutic agents.
Topics: Aldehydes; Amides; Amines; Animals; Antineoplastic Agents; Asparaginase; Azacitidine; Azaguanine; Bleomycin; Carmustine; Chlorides; Cyclization; Cyclohexanes; Cytarabine; Cytidine; Doxorubicin; Glycosides; Humans; Hydroxyurea; Imidazoles; Leukemia, Lymphoid; Leukemia, Myeloid; Mice; Nitrosourea Compounds; Picolinic Acids; Platinum; Podophyllotoxin; Streptozocin; Thiosemicarbazones; Triazenes | 1972 |
5 trial(s) available for podophyllotoxin and Granulocytic Leukemia
| Article | Year |
|---|---|
High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Risk Factors | 1997 |
Podophyllotoxin derivative VP 16-213.
Topics: Animals; Bronchial Neoplasms; Carcinoma; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; In Vitro Techniques; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma; Mice; Neoplasms; Podophyllotoxin; Rabbits; Rats; Sarcoma | 1979 |
VP 16-213 in acute myelogenous leukaemia.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1976 |
Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Evaluation; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Podophyllotoxin; Teniposide | 1976 |
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk Factors; Teniposide | 1991 |
21 other study(ies) available for podophyllotoxin and Granulocytic Leukemia
| Article | Year |
|---|---|
Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Topics: Acute Disease; Alkylating Agents; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin | 2007 |
[Diagnosis and therapy of chronic monocytic leukemia].
Topics: Aged; Chromosome Aberrations; Colloids; Diagnosis, Differential; Female; Humans; Hydroxyurea; Indium; Leukemia, Myeloid; Male; Mercaptopurine; Monocytes; Phagocytosis; Podophyllotoxin | 1981 |
Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis.
Topics: Adult; Chromosomes, Human, 21-22 and Y; Etoposide; Fever; Heart Arrest; Humans; Hypocalcemia; Leukemia, Myeloid; Male; Phosphates; Podophyllotoxin; Syncope | 1984 |
The epipodophyllotoxins: both sides of the coin.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Topics: Acute Disease; Adolescent; Alkylating Agents; Antineoplastic Agents; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Topoisomerase II Inhibitors; Translocation, Genetic | 1993 |
Secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Failure | 1993 |
Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins.
Topics: Acute Disease; Adult; Child; Clinical Trials as Topic; Etoposide; Humans; Incidence; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Podophyllotoxin | 1995 |
Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Survival Analysis | 1997 |
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine | 1999 |
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms | 1975 |
Chronic myelomonocytic leukaemia: a case report.
Topics: Aged; Chronic Disease; Etoposide; Humans; Leukemia, Myeloid; Male; Podophyllotoxin | 1977 |
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Chemical Phenomena; Chemistry; Chronic Disease; Drug Evaluation; Female; Glucosides; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1975 |
Therapy-related myeloid leukaemia.
Topics: Acute Disease; Child; Humans; Leukemia, Myeloid; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 1990 |
Severe hypertensive reactions to teniposide (VM-26) in infants with congenital leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hypertension; Infant; Infant, Newborn; Leukemia, Lymphoid; Leukemia, Myeloid; Podophyllotoxin; Teniposide | 1987 |
Allogeneic bone marrow transplantation as primary therapy for chronic myelomonocytic leukemia.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid; Podophyllotoxin; Radiotherapy Dosage; Remission Induction; Time Factors; Transplantation, Homologous | 1987 |
Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
Topics: Bone Marrow; Cell Survival; Cells, Cultured; Doxorubicin; Drug Synergism; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Macrophages; Podophyllotoxin; Verapamil; Vincristine | 1985 |
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Leukemia, Myeloid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Remission, Spontaneous | 1974 |
[Remission in severe chronic myeloid leukemia after cytostatic treatment].
Topics: Humans; Leukemia, Myeloid; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum | 1966 |
[On a long lasting remission of myelocytic leukemia following cytostatic therapy].
Topics: Antineoplastic Agents; Blood Platelet Disorders; Humans; Injections, Intravenous; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Splenic Diseases | 1966 |
[Clinical findings in podophyllotoxin derivatives (SP-I-SP-G) in malignant tumors].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Stomach Neoplasms | 1968 |